CH505 M5 gp120 Env
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CH505 M5 gp120 Env, covering 2023-02-01 to 2023-02-01. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Safety and Immunogenicity of EnvSeq-1 and CH505 M5 gp120 Envs Adjuvanted With GLA-SE in Healthy, HIV-Uninfected Adults [Phase 1]